Qlife's Board of Directors and management exercise warrants of series TO1 for SEK 2.4 million
Members of the Board of Directors and management of Qlife have exercised warrants of series TO1. The subscription period for the warrants of TO1 began on May 3 and runs until May 31, 2021.
The warrant holders have the right to subscribe for one (1) new share in Qlife for each two (2) owned warrants of series TO1 at a price of SEK 17.50 per share. The number of warrants of series TO1 that have been exercised by members of the Board of Directors and management amounts to 269,352, corresponding to a subscription of 134,676 shares with a value of SEK 2,356,830.
Thomas Warthoe sells 1,200,000 warrants to a number of investors and to board member Mikael Persson. Thomas Warthoe intends to use the proceeds from the sale to subscribe for an additional 61,951 shares during the exercise period.
Today, Thomas Warthoe privately owns a total of 243,902 shares and through the company PKV Consult an additional 1,201,200 shares.
The Board of Directors and management exercise their warrants of TO1 as follows:
Thomas Warthoe, CEO and board member
Exercise 123,902 TO1, corresponding to SEK 1,084,142.50
John Moll, Board member
Exercise 81,300 TO1, corresponding to SEK 711,375
Mette Gross, Chairman
Exercise 40,650 TO1, corresponding to SEK 355,687.50
Mikael Persson, Member
Exercise 20,000 TO1, corresponding to SEK 175,000
Jacob Broberg Lind, Sales Director Clinical
Exercise 3,500 TO1, corresponding to SEK 30,625
For more information please contact:
Mette Gross, Chair Qlife Holding AB
E-mail: [email protected]
Tel. No.: +46 (0)73-517 85 25
Qlife is a medical device company that seeks to revolutionize the clinical biomarker market for whole blood testing by taking it out of the lab and into the homes. This will facilitate easy access to blood sample results and in turn facilitate increased monitoring of parameters that enables care improvement.
Shares for Qlife are being traded on Nasdaq First North Growth Market in Stockholm with G&W Fondkommission as certified advisor (phone: +46 (0) 8-503 000 50, e-mail: [email protected]).
NOTICE TO ANNUAL GENERAL MEETING IN BRIGHTER AB (PUBL)
Notice of attendance shall be made in writing to Brighter AB (publ), Borgarfjordsgatan 18, 164 40 Kista or by email to [email protected] On giving notice of attendance, the shareholder should state the shareholder’s name, personal identity number or equivalent /corporate identity number, address...
Bronson Methodist Hospital beställer WasteLog®
Bronson Methodist Hospital är ett undervisningssjukhus och traumacenter med totalt 424 vårdplatser beläget i centrala Kalamazoo, Michigan. Bronson Methodist Hospital är flaggskeppet för Bronson Healthcare Group, ett ideellt sjukvårdssystem som har totalt fyra sjukhus...
Bronson Methodist Hospital implements WasteLog®
Bronson Methodist Hospital is a 434-bed teaching hospital and trauma center located in central Kalamazoo, Michigan. Bronson Methodist Hospital is the flagship of the Bronson Healthcare Group, a nonprofit healthcare system with a total of four hospitals located in southwest Michigan and northern Indi...